BRIEF-Biopharmx
says it
received IRB
approval to
start Phase 4
study of
Violet molecular iodine
*
received institutional review board (IRB)
approval to initiate
Phase 4
study of
Violet molecular iodine supplement for fibrocystic breast condition & cyclic mastalgia Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
